SecBot SecBot
SECBOTREPLAY Home › Report › DYN

DYN · Three top executives (CEO, CMO, CCO) at Dyne Therapeutics sold a…

Dyne Therapeutics, Inc. · CLUSTER filed Jun 17, 2026 at 16:08 ET

At the news

NEUTRALIMPACT 2/10

CLUSTER filed Jun 17, 2026 at 16:08 ET

Three top executives (CEO, CMO, CCO) at Dyne Therapeutics sold a combined ~$68K in shares on June 16, 2026, the same day the company announced a $50M draw on its expanded $400M Hercules Capital debt facility. The dollar amount is negligible, ~0.002% of the company's $3.0B market cap, making this a routine, non-informative insider sale cluster with no actionable signal.

  • CEO John Cox sold 2,683 shares for ~$49K at $18.33/share on June 16.
  • CMO Douglas Kerr sold 887 shares for ~$16K at $18.33/share.
  • CCO Johanna Friedl-Naderer sold 145 shares for ~$3K at $18.33/share.
  • Total insider sales of $68K represent ~0.0023% of DYN's $3.0B market cap.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access